EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Flotillin‐1 is a prognostic biomarker for glioblastoma and promotes cancer development through enhancing invasion and altering tumour microenvironment

Ran Wang iD, Zhikang Chen, Yi Zhang, Shihan Xiao, Wuming Zhang, Xianqin Hu, Qun Xiao, Qing Liu iD, Xiangyu Wang iD

Journal of Cellular and Molecular Medicine · 2023

DOI: 10.1111/jcmm.17660 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2023. Verfasst von Ran Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal and Anus Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Flotillin‐1(FLOT1) has long been recognized as a tumour‐promoting gene in several types of cancer. However, the expression and function of FLOT1 in glioblastomas (GBM) has not been elucidated. Here, in this study, we find that the expression level of FLOT1 in GBM tissue was much higher than that in normal brain, and the expression was even higher in the more aggressive subtypes and IDH status of glioma. Kaplan–Meier survival revealed that high FLOT1 expression is closely associated with poor outcome in GBM patients. FLOT1 knockdown markedly reduced the proliferation, migration and invasiveness of GBM cells, while FLOT1 overexpression significantly increases GBM cell proliferation, migration and invasiveness. Mechanistically, FLOT1 expression may play a potential role in the microenvironment of GBM. Therefore, FLOT1 promotes GBM proliferation and invasion in vitro and in vivo and may serve as a biomarker of prognosis and therapeutic potential in the fight against GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsHumansPrognosisTumor MicroenvironmentCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticNeoplasm InvasivenessCell MovementMembrane Proteins

Stichwörter der Autor:innen

flotillin-1glioblastomainvasivenessprognostic biomarkertumour microenvironment

Substanzen

flotillinsMembrane Proteins

Autor:innen und Institutionen

  • Department of Colorectal and Anus Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • The Hunan Provincial Key Lab of Precision Diagnosis and Treatment for Gastrointestinal Tumor, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Department of Neurosurgery, Dengzhou People's Hospital, Dengzhou, Henan, China.
  • Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.

ORCID-Profile: Ran Wang, Qing Liu, Xiangyu Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, R., Chen, Z., Zhang, Y., Xiao, S., Zhang, W., Hu, X., Xiao, Q., Liu, Q., & Wang, X. (2023). Flotillin‐1 is a prognostic biomarker for glioblastoma and promotes cancer development through enhancing invasion and altering tumour microenvironment. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.17660

Vancouver

Wang R, Chen Z, Zhang Y, Xiao S, Zhang W, Hu X, et al. Flotillin‐1 is a prognostic biomarker for glioblastoma and promotes cancer development through enhancing invasion and altering tumour microenvironment. Journal of Cellular and Molecular Medicine. 2023. doi:10.1111/jcmm.17660

BibTeX
@article{Wang2023,
  author = {Wang, Ran and Chen, Zhikang and Zhang, Yi and Xiao, Shihan and Zhang, Wuming and Hu, Xianqin and Xiao, Qun and Liu, Qing and Wang, Xiangyu},
  title = {Flotillin‐1 is a prognostic biomarker for glioblastoma and promotes cancer development through enhancing invasion and altering tumour microenvironment},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2023},
  doi = {10.1111/jcmm.17660}
}
Kostenlos starten →